FDA Approvals

Date Posted
Article Title
5/17/2012
5/1/2012
Elelyso Approved for Gaucher Disease

People with rare disorder lack enzyme

4/27/2012
Levaquin Approved to Treat or Prevent Plague

Deadly disease rare in the United States

4/27/2012
Votrient Approved to Treat Cancer That Begins in Soft Tissue

Drug inhibits process that fuels tumor growth

4/27/2012
Afinitor Approval Expanded to Include Benign Kidney Tumors

Growths caused by rare genetic disease

4/13/2012
Drug Approved to Treat High Blood Pressure

Dutoprol combines antihypertensive and diuretic

3/27/2012
Omontys Approved for Anemic People With Kidney Disease

Drug designed to stimulate production of red blood cells

3/23/2012
New Device Approved for Lingering GERD

After lifestyle changes, medication fail to relieve symptoms

3/19/2012
3/14/2012
First Generic Lexapro Approved

To treat depression and general anxiety disorder

3/9/2012
New Silicone Breast Implant Approved

The third such implant sanctioned in the U.S.

3/7/2012
Drug Approved to Prevent Respiratory Distress Syndrome

Surfaxin treats lung disorder that affects premature babies

3/1/2012
Two Pancreatic-Enzyme Products Approved

To aid in food digestion

2/28/2012
Autoinjector Version of MS Drug Approved

Avonex pen helps reduce pain, anxiety

2/24/2012
Children Now Eligible for Screening Test for Bacterium

Helicobacter pylori causes ulcers, gastritis, certain cancers

2/21/2012
2/20/2012
Korlym Approved for Cushing's Syndrome

Blocks effects of too much cortisol, the so-called 'stress' hormone

2/13/2012
2/8/2012
Prescription Shampoo Approved to Treat Head Lice

Sklice is sanctioned for children as young as six months

2/1/2012
Gleevec Approval Widened to Include Rare Cancer

CD117-positive gastrointestinal stromal tumors